This movie is featuring the Global Ibogaine Conference that was held in Mexico in March, filmed by a member of Drugreporter’s new global video network and an alumni of our video advocacy training, Brun Balanced and his peers, Karina Muscarina and Gabriel Amezcua.
Every cannabis smoker knows that the major psychoactive ingredient of the plant is Δ9-tetrahydrocannabinol (THC), but there is also a range of other chemicals in marijuana smoke. One of the other significant components is cannabidiol (CBD). Anecdotal evidence suggests that CBD can inhibit some negative side effects associated with marijuana, but does this claim stand up to scientific scrutiny?
The research with psychedelic drugs can change our understanding of the human mind. Watch our video report from the International Interdisciplinary Conference on Psychedelic Research! Watch some of the key presentations too!
Leading national and international experts and activists discussed barriers and opportunities at the first conference on medical cannabis in Hungary.
Medical cannabis activists formed an alliance with a political party, in order to contest the parliamentary elections in Serbia. Read Irena Molnar’s report from Belgrade, and watch the video!
A surprise decision from the otherwise super-conservative Polish government: it improves access to cannabis for medical purposes.
Progress should not cause us to lose sight of our core values. Please watch our video and read our article about the 2015 International Drug Policy Reform Conference, which was held in Washington DC between 18-21 November!
A speech delivered by the Director of the Drug Policy Alliance at the opening session of the International Drug Policy Reform Conference in Washington DC.
Scientists at the University of Debrecen, Hungary, are aiming to work on cutting-edge research to study how endogenous DMT, occurring naturally in the body, may be useful to modern medicine, particularly by protecting brain cells in the stage of clinical death.
The Hungarian government banned 42 new psychoactive substances this year – but some of them are not new at all, for example Ibogaine. The Hungarian Civil Liberties Union is suing a government agency for not providing access to the assessment reports on the risks of these drugs.